Tagged Articles

Ben Venue Laboratories 3 articles

Glass particles found in inhaled respiratory treatment

Ben Venue Laboratories has issued a nationwide recall of an inhaled Acetylcysteine solution to treat specific respiratory conditions because of the possibility of glass particles in the solution. Inhaling these particles can cause airway obstruction that can lead to choking, wheezing, difficulty breathing, coughing and possibly hemoptysis, or blood in the mucus. These problems can be life threatening and could also result in recurrent infections due to obstruction of airways and decreased clearance of airway secretions. Acetylcysteine is a drug that is inhaled to clear mucus and material entrapped in mucus in people who have thick mucus that may interfere ... Read More

FDA approves generic cancer drug to cover drug shortages caused by quality control issues at manufacturing plant

The first generic version of the cancer drug Doxil has been approved by the Food and Drug Administration (FDA), which may help a drug shortage that has led to rationing and less-effective care for cancer patients. Doxil was approved in 1995 to treat ovarian cancer, AIDS-related Kaposi’s sarcoma and multiple myeloma. The drug is made by Johnson & Johnson under contract by manufacturer Ben Venue Laboratories, a unit of German drug maker Boehringer Ingelheim. Supplies from Ben Venue began running short due to quality control problems. In November 2011, operations at Ben Venue were suspended after an FDA investigation found ... Read More

Bristol-Myers Squibb recalls chemotherapy drug

More than 31,000 units of a chemotherapy drug are being recalled by manufacturer Bristol-Myers Squibb Co., because one vial was found to be overfilled, which puts patients at risk for overdose. The recall affects 10 lots of BiCNU, an injection of the drug carmustine, which is used to treat brain tumors, multiple myeloma, Hodgkin’s disease and non-Hodgkin’s lymphoma. An overdose of BiCNU could result in lung or kidney toxicity. No adverse events have yet been reported. BiCNU was manufactured by Ben Venue Laboratories, a manufacturing contractor that Bristol-Myers Squibb no longer uses. The recall affects products sold in the United ... Read More